Independent association of von Willebrand factor with surrogate markers of atherosclerosis in middle‐aged asymptomatic subjects
暂无分享,去创建一个
J. Paramo | J. Díez | J. Orbe | O. Beloqui | I. Colina
[1] G. Lip,et al. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. , 2005, Blood.
[2] Arshed A Quyyumi,et al. Surrogate Markers for Cardiovascular Disease: Functional Markers , 2004, Circulation.
[3] B. Dahlöf,et al. Surrogate markers for cardiovascular disease: structural markers. , 2004, Circulation.
[4] J. Paramo,et al. Prothrombin Fragment 1+2 Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Cardiovascular Disease , 2004, Stroke.
[5] D. Arveiler,et al. Endothelial Cell Markers and the Risk of Coronary Heart Disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study , 2004, Circulation.
[6] Amir Lerman,et al. Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[7] L. Bouter,et al. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[8] G. Lowe,et al. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study , 1999, British journal of haematology.
[9] P. Mannucci,et al. von Willebrand factor: a marker of endothelial damage? , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[10] E. Vicaut,et al. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. , 1998, Circulation.
[11] G. Lip,et al. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? , 1997, Cardiovascular research.
[12] J. Ware,et al. Structure and Function of von Willebrand Factor , 1992, Thrombosis and Haemostasis.